Name: Latest research reports of Rossari Biotech Ltd. authored by ICICI Securities Limited and published by - Trendlyne research reports.
Item: Rossari Biotech Ltd.
Rating: 3
Author: ICICI Securities Limited

Rossari Biotech Ltd.

NSE: ROSSARI | BSE: 543213 | ISIN: INE02A801020 | Industry: Specialty Chemicals
| Mid-range Performer

693.1000 12.10 (1.78%)

NSE Apr 21, 2025 15:31 PM

28.74% Fall from 52W High

Volume: 327.1K

High volume today

Rossari Biotech Ltd.

03 May 2023

693.10

1.78%

Unexciting performance

Hold: Rossari Biotech Ltd.

Target

ICICI Securities Limited

Rossari Biotech’s Q4FY23 revenue dipped 7.4% YoY (rose 4.4% QoQ) to Rs4.1bn due to drop in raw material prices. However, we were disappointed by a 40bps QoQ contraction in gross profit margin to 29.6%. EBITDA growth therefore was just 4.3% YoY.

Rossari Biotech Ltd. is trading below its 100 day SMA of 722.0